Related Experiment Videos

Aspergilloma: a series of 89 surgical cases

J F Regnard1, P Icard, M Nicolosi

  • 1Department of Thoracic Surgery, Marie Lannelongue Hospital, Le Plessis Robinson, France.

Abstract

Insights

Surgical resection effectively treats pulmonary aspergilloma, preventing hemoptysis recurrence. The procedure is low-risk for asymptomatic patients without lung disease, but high-risk patients may benefit from cavernostomy.

Area of Science:

  • Pulmonology
  • Thoracic Surgery
  • Infectious Diseases

Background:

  • Pleuropulmonary aspergilloma surgery is considered high-risk.
  • A review of surgical outcomes focused on postoperative complications.

Purpose of the Study:

  • To evaluate the safety and efficacy of surgical resection for pleuropulmonary aspergilloma.
  • To identify risk factors for postoperative complications and long-term outcomes.

Main Methods:

  • Retrospective review of 87 patients undergoing surgery for pulmonary or pleural aspergillomas over 20 years.
  • Analysis of surgical procedures, including lobectomy, segmentectomy, pneumonectomy, and cavernostomy, and associated patient characteristics.
  • Evaluation of postoperative complications, mortality, and long-term recurrence rates.

Main Results:

  • 89 resections were performed; 70% of aspergillomas were in tuberculosis sequelae.
  • Postoperative mortality was 5.7% (5 deaths), primarily due to respiratory failure.
  • Incomplete lung reexpansion was common after lobectomy/segmentectomy, especially with underlying lung disease. No deaths occurred in asymptomatic patients.

Conclusions:

  • Surgical resection is effective for preventing recurrent hemoptysis in aspergilloma patients.
  • Asymptomatic patients without underlying lung disease have a low surgical risk.
  • Cavernostomy is a viable option for high-risk patients; long-term prognosis depends on overall patient condition.

Related Concept Videos